GlobalData02.15.22
Steady and stable.
That is the forecast for Japan's vascular embolization plugs and coils market, which is forecast to grow 3 percent annually this decade, according to Globaldata.
“Embolization coils are preferred over embolization plugs in treating patients with peripheral aneurysms, type II endoleaks and gastrointestinal bleeding due to factors such as low cost, ease of deployment, availability of variety of options in terms of diameter and length of the coil and better patient outcomes,” said Tanisha Verma, a senior medical devices analyst at GlobalData.
The sector is expected to be driven by a growing preference for endovascular minimally invasive procedures over traditional surgeries. Detachable coils accounted for more than 80 percent of the vascular embolization plugs and coils market in Japan last year. The average number of embolization coils used per procedure varies depending on the factors such as size of the aneurysm, length of the coil and skill set of healthcare professional.
GlobalData's report, “Vascular Embolization Plugs and Coils (Cardiovascular) – Global Market Analysis and Forecast Model (COVID-19 Market Impact),” reveals that Terumo Corp. and Boston Scientific Corp. are the leading players in Japan, together accounting for more than 45 percent of the overall vascular embolization plugs and coils market in 2021.
“Vascular embolization plugs and coils have gained popularity over time not just because of their efficiency in treating aneurysms but also due to the advancements offered in this field. However, factors such as high cost of embolization plugs, lack of required number of trained specialists available, limited access to diagnostic facilities to rural population and post-procedural complications such as thrombosis and occlusion of non-target vessel should be addressed to further drive the market,” Verma said.
That is the forecast for Japan's vascular embolization plugs and coils market, which is forecast to grow 3 percent annually this decade, according to Globaldata.
“Embolization coils are preferred over embolization plugs in treating patients with peripheral aneurysms, type II endoleaks and gastrointestinal bleeding due to factors such as low cost, ease of deployment, availability of variety of options in terms of diameter and length of the coil and better patient outcomes,” said Tanisha Verma, a senior medical devices analyst at GlobalData.
The sector is expected to be driven by a growing preference for endovascular minimally invasive procedures over traditional surgeries. Detachable coils accounted for more than 80 percent of the vascular embolization plugs and coils market in Japan last year. The average number of embolization coils used per procedure varies depending on the factors such as size of the aneurysm, length of the coil and skill set of healthcare professional.
GlobalData's report, “Vascular Embolization Plugs and Coils (Cardiovascular) – Global Market Analysis and Forecast Model (COVID-19 Market Impact),” reveals that Terumo Corp. and Boston Scientific Corp. are the leading players in Japan, together accounting for more than 45 percent of the overall vascular embolization plugs and coils market in 2021.
“Vascular embolization plugs and coils have gained popularity over time not just because of their efficiency in treating aneurysms but also due to the advancements offered in this field. However, factors such as high cost of embolization plugs, lack of required number of trained specialists available, limited access to diagnostic facilities to rural population and post-procedural complications such as thrombosis and occlusion of non-target vessel should be addressed to further drive the market,” Verma said.